Canada Research Roundup: Canadian National Railway, HLS Therapeutics, Rogers Communications

Canadian National Railway Co

31/01/2025 07:17

Jan 31 (Reuters) - Securities analysts revised their ratings and price targets on
several Canadian companies including Canadian National Railway ,HLS Therapeutics and Rogers
Communications on Friday. 
    
    HIGHLIGHTS 
     * Canadian National Railway Co  CNR.TO : JP Morgan cuts target price to C$174 from C$179
     * HLS Therapeutics Inc  HLS.TO : Canaccord Genuity raises PT to C$4.25 from C$3.5
     * Rogers Communications Inc  RCIb.TO : JP Morgan cuts target price to C$57 from C$63
 Following is a summary of research actions on Canadian companies reported by Reuters on Friday.
Stock entries are in alphabetical order.
    
     * Canadian National Railway Co  CNR.TO : JP Morgan cuts target price to C$174 from C$179
     * Canadian National Railway Co  CNR.TO : TD Cowen raises target price to C$171 from C$170
     * HLS Therapeutics Inc  HLS.TO : Canaccord Genuity raises PT to C$4.25 from C$3.5
     * Rogers Communications Inc  RCIb.TO : Canaccord Genuity cuts PT to C$42 from C$46
     * Rogers Communications Inc  RCIb.TO : JP Morgan cuts target price to C$57 from C$63
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))